Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health

Obstetrics & Gynecology Science

Hee Dong Chae¹  Jae Hoon Lee²  Ji Young Lee³  Kyong Wook Yi⁴  Jung-Ho Shin⁴  Kyu Ri Hwang⁵  Jin Ju Kim⁶  Jae Yen Song⁷ 

[1] Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea;Konkuk University School of Medicine, Seoul, Korea;Korea University College of Medicine, Seoul, Korea;SMG-SNU Boramae Medical Center, Seoul, Korea;Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea;Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea;

关键词: covid-19;    covid-19 vaccines;    contraception;    contraceptives;    oral;    combined;    long-acting reversible contraception;   

DOI  :  10.5468/ogs.21322

来源: DOAJ

【 摘 要 】

Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic.

【 授权许可】

Unknown